This brand name is authorized in Nigeria.
The drug OCUQUIN contains a combination of these active pharmaceutical ingredients (APIs):
1
|
UNII
60W3249T9M - ARTESUNATE
|
|
Artesunate is a semi-synthetic artemisinin derivative, indicated for the initial treatment of severe malaria in adults and children. The antimalarial mechanism of action of artesunate is generally thought to depend upon activation involving iron-mediated cleavage of the endoperoxide bridge of DHA to generate an unstable organic free radical followed by alkylation, where the free radical binds to malarial proteins leading to destruction of parasite membranes. |
|
2
|
UNII
5Y9L3636O3 - MEFLOQUINE HYDROCHLORIDE
|
|
Mefloquine acts on and destroys the asexual intraerythocytic forms of the human malaria parasites: Plasmodium falciparum, P. vivax. P. malariae and P. ovale. It is effective in the treatment and prophylaxis of malaria. |
|
This drug has been approved in Nigeria as follows:
| Identifier | Form | Presentation | Description | Approval |
|---|---|---|---|---|
| A4-101092 | Tablet | Ocuquin 300/375 Tablets TAB 100 mg; 125 mg 10 x 1 x 6's (in PVC-Alu blisters) | Tablet | 22/11/2024 |
| A4-101093 | Tablet | Ocuquin 600/750 Tablets TAB 200 mg; 250 mg 10 x 1 x 6's (in PVC-Alu blisters) | Tablet | 22/11/2024 |
This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:
| ATC Group | Classification | |
|---|---|---|
| P01BF02 | Artesunate and mefloquine | P Antiparasitic products, insecticides and repellents → P01 Antiprotozoals → P01B Antimalarials → P01BF Artemisinin and derivatives, combinations |
This drug has been assigned below unique identifiers within the countries it is being marketed:
| Country | Identification scheme | Identifier(s) |
|---|---|---|
| NG | Registered Drug Product Database | A4-101092, A4-101093 |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.